CAPP3: a randomized dose finding non inferiority study of aspirin to prevent cancer in Lynch Syndrome

Colorectal Cancer

Lead Researcher: Professor Finlay Macrae

Institution: Melbourne Health

Funding: $290,340.50

Funding Duration: 2016 – 2018

The Research

A trial to establish whether lower doses of aspirin are equally effective for cancer prevention making public health messages uniform across cardiovascular disease and cancer.


Similar research

No items found.